Dr. Eric Leire, MD, MBA, is the CEO and Founder of GenFlow Biosciences. He has an impressive background in the biotechnology and gene therapy sector. Furthermore, Eric has a plethora of remarkable experience in the pharmaceutical industry, having held Pfizer, Schering Plough, and Pharmacia posts. His success has also translated into academic research, where he has held a research position at Harvard University.
In addition, his career has soared throughout the biotechnology industry, being the CEO of several private and public biotech companies. He is also the inventor of several patents and serves on the board of several biotechnology companies, such as Pherecydes (ALPHE.PA), Immunethep (developing a Covid vaccine), Inhatarget, and BSIM.
With the Biotech sector forecast to grow close to $2.5 trillion by 2028 – the financial benefits are straightforward and the moral importance to serve societal needs. In addition, research into longevity and healthy aging have progressed rapidly in recent years. We chatted with Eric, who explains how developments in the biotechnology sector can aid the longevity research process.
“Many US biotech companies shifted their research focus to improving longevity. However, only a few European biotech companies are working on a science-based development of therapeutic interventions that could delay the aging process.”
He continues, “Our company is interested in identifying the genetic and molecular pathways underpinning the aging process.” Specifically, Genflow Biosciences’ work is based on the fact that DNA repair plays a crucial role in determining an organism’s lifespan. As humans and other mammals grow older, our DNA is more and more prone to breaks. GenFlow intends to provide extra copies of a gene involved in DNA repair called SIRT6 and, more specifically, a variant of the SIRT6 found in centenarians. The additional copies of centenarian SIRT6 will improve the ability to repair DNA damage.
The feasibility of gene transfer to patients was demonstrated around 30 years ago and these methods have improved substantially. As a result, many commercial gene therapy candidates are now focussing on gene therapy for multiple diseases.
Scientists now can inject more efficient AAVs that can express a transgene such as SIRT6 into specific cells. Like other viruses, the tropism of an AAV for particular cells is controlled by the particular interaction between the proteins of its capsid (the protein shell enclosing the AAV genetic material) and the receptors of the targeted cells. In the last decade, there has been a tremendous advance in the ability to design novel, highly efficient AAVs that can target specific cells or organs.
Having a toolbox of enhanced AAVs is an important step; however, to develop an effective SIRT6 gene delivery, we also needed an understanding of the potential immunity to AAVs. A pre-existing barrier to AAV gene delivery stems from our natural exposure to AAV, resulting in a possible pre-existing humoral and cellular immunity to AAVs. Even a highly efficient and specific AAV delivering an ideal transgene (such as SIRT6) means nothing if an immune response prevents the AAV from reaching the appropriate cells. Therefore, it is critical when translating AAV gene delivery for clinical applications first to determine whether the patient has pre-existing immunity to AAV and then mitigate the development of potentially damaging immune responses when the gene is delivered intravenously. Fortunately, several studies have assessed the immune response to AAV-mediated gene therapy in both pre-clinical models and human patients. Overcoming pre-existing immunity is not trivial, but we now have strategies to enable AAV treatment without triggering immunity.
Eric believes that GenFlow’s contribution to advancing the understanding of anti-AAV immunity in our pre-clinical program. During clinical trials will help not only the development of our product but will also participate in the development of other safe and highly efficacious AAV therapies for other diseases such as neurodegenerative diseases, cardiovascular diseases, and cancer.
What Makes Meme Coins Like Floki Inu Popular?
The cryptocurrency market is evolving and among the meme coins the latest star is Floki Inu, the now popular meme coin. It was in June when Elon Musk had tweeted he intends to name his Shiba Inu Floki that led to a developer inspired to make Floki. The coin was made in August by a developer named Ryoshi.
Today whenever Elon Musk shares something about his Shiba Inu it affects the coin’s market. Like in March 2021 he wrote ‘I am getting a Shiba Inu’, in June, ‘My Shiba Inu will be named Floki’ and in September he wrote ‘Floki has arrived’ the meme coin Floki Inu rose by 1,000 percent in 2 days.
This meme coin which is community owned has since then rapidly grown. It has been inspired by Tesla and SpaceX boss Elon Musk’s Shiba Inu, mentions Floki’s website. Now the Floki Inu trades at $0.00007731 with a trading volume of over $16 million.
When a cryptocurrency is associated with a theme it is called a meme coin. Named after a popular dog, the Dogecoin was the 1st meme coin. Shiba Inu and Floki Inu are other meme coins. These meme coins are all hyper volatile cryptocurrencies. Experts are researching the reasons why the meme coins are seeing a steep rise.
The reasons propagated why the meme coins are so popular is one: they have the presence of a strong community and second the presence of strong personality cults. Like in the case of Floki Inu it is Elon Muskwho has thrown his weight behind the meme coin through his tweets. Another reason could be the low entry level prompts retail investors excited to invest in meme coins thus taking their price higher.
- Things You Can Do To Make The World A Better Place January 27, 2022
- Importance of hiring Structural Engineers Miami when purchasing a house January 26, 2022
- What Is Debt Consolidation and How Does It Work? January 25, 2022
- Fitafy Is a Viral Dating App That Matches Health-Conscious Singles Based on Lifestyle Interests January 25, 2022
- 3 Ways The Law of Attraction Can Improve Your Lifestyle January 25, 2022
- Attracting eyeballs and how – make way for the newest sensational page on Instagram, “Las Vegas Scoop.” January 22, 2022
- 7 Common Mistakes to Avoid When Submitting a 510K to the FDA January 21, 2022
- Innovation Leads to Winning Smiles: Lebanese Dentist Dr. Mohammad Waizani Offers Insight Into the Science of Quality Veneers January 20, 2022
- Charlotte Fenna Aim to Embark on a Humble Quest With EP January 20, 2022
- How to increase sales and supply chain efficiency through a product configurator January 20, 2022
Tech10 months ago
Effuel Reviews (2021) – Effuel ECO OBD2 Saves Fuel, and Reduce Gas Cost? Effuel Customer Reviews
Tech2 years ago
Bosch Power Tools India Launches ‘Cordless Matlab Bosch’ Campaign to Demonstrate the Power of Cordless
Lifestyle3 years ago
Catholic Cases App brings Church’s Moral Teachings to Androids and iPhones
Lifestyle12 months ago
East Side Hype x Billionaire Boys Club. Hottest New Streetwear Releases in Utah.
Tech3 years ago
Cloud Buyers & Investors to Profit in the Future
Lifestyle1 year ago
The Midas of Cosmetic Dermatology: Dr. Simon Ourian
Health3 years ago
CBDistillery Review: Is it a scam?
Entertainment2 years ago
Avengers Endgame now Available on 123Movies for Download & Streaming for Free